The Pillai Lab
Our research groups focuses on translational studies and novel diagnostic strategies for infectious pathogens including SARS-CoV-2, malaria, dengue, C. difficile, and more.
What Do We Work On?
VISION
To lead the future of infectious disease diagnostics by revolutionizing point-of-care and near-patient testing, empowering equitable healthcare access worldwide, and advancing breakthroughs in understanding disease pathogenesis.
MISSION
To improve global health by advancing accessible, cost-effective point-of-care diagnostic solutions, reducing healthcare costs, and improving patient outcomes.
OBJECTIVES
(a) Development and Validation of Point-of-Care Assays: Innovating and rigorously validating diagnostic tools to accurately detect infectious diseases at the point-of-care.
(b) Platform Technology Innovation: Creating scalable, versatile technologies to drive the evolution of point-of-care and near-patient testing solutions.
(c) Decoding Infectious Disease Pathogenesis: Exploring the biological mechanisms underpinning infectious diseases to inform diagnostics and therapeutic advancements.
NEW!! ddPCR Services Available!
